Correction: Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease
Magdaléna Neřoldová(Charles University), M Jirsa, Alena Vrbacká(Charles University), Viktor Stránecký(Charles University), Lenka Mrázová(Charles University), Petra Lišková(Charles University), Milan Maçek(Charles University), Joanna Pawłowska(Children's Memorial Health Institute), Janka Slatinská(Institute of Clinical and Experimental Medicine), Hana Zůnová(Charles University), Radana Kotalová(Charles University), Elżbieta Ciara(Children's Memorial Health Institute), A. S. Knisely(Medical University of Graz), Ondřej Fabián(Charles University), Lucie Pfeiferová(Institute of Molecular Genetics), Eva Sticová(Institute of Clinical and Experimental Medicine), Daniela Škanderová(University Hospital Olomouc), Jan Šperl(Institute of Clinical and Experimental Medicine), Markéta Šafaříková(Charles University), Stanislav Kmoch(Charles University), Soňa Fraňková(Institute of Clinical and Experimental Medicine), Tomáš Zima(Charles University), Janka Globinovská, Marta Kalousová(Charles University)
Cited by 0
Related Papers
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
The origin of the major cystic fibrosis mutation (ΔF508) in European populations
|Nature Genetics|1994|347
Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing
|Nature Genetics|2013|317
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
|Journal of the American Society of Nephrology|2015|284
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis
|Nature Genetics|2006|250